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induced MPT, respiration, and phospholipid fatty acyl composition.
Both DHA and EPA enriched diets lowered circulating free fatty acids
and triglycerides byapproximately 40% (p<0.05, DHAvs CTRL and EPA
vs CTRL, NS, DHAvs EPA). DHA supplementation increasedDHAby 63%
(p<0.05 vs control) and decreased ARA by 61% (p<0.05 vs control) in
mitochondrial phospholipids, and significantly delayedMPTP opening
(57% more calcium necessary to induce MPTP vs CTRL, p<0.05). EPA
supplementation did not affect DHA, only modestly lowered ARA
(−33% vs CTRL, p<0.05), and had no effect of MPTP opening. State 3
respiration with a variety of substrates was unaffected by dietary
treatment, however DHA decreased state 4 respiration by 30% and the
increased RCR by 70% with pyruvate+malate as the substrate, both in
the absence and presence of oligomycin (p<0.05); treatmentwith EPA
had no effect. The P:O ratiowas not different among groupswith any of
the substrates. In summary, DHA supplementation favorably altered
mitochondrial phospholipid composition and delayed MPT in cardiac
mitochondria, while EPA had no effect. These effects may contribute to
the protection against heart disease with ω-3 PUFA supplementation,
and suggest that supplementationwithDHA should be superior to EPA.
doi:10.1016/j.bbabio.2010.04.243
9P.6 Nitrolinoleate modifies ANT, KATP channels and complex II
and modulates their activity
Sergiy M. Nadtochiy1, Andrew P. Wojtovich2, Paul S. Brookes1
1University of Rochester, Department of Anesthesiology, USA
2University of Rochester, Department of Pharmacology and Physiology,
USA
E-mail: Sergiy_Nadtochiy@urmc.rochester.edu
Nitroalkenes are electrophilic molecules which can cause post-
translational modifications of proteins and modulate their functional
activity. Previously we demonstrated endogenous formation of ni-
trated linoleate (LNO2) in mitochondria isolated from perfused heart
after ischemic preconditioning. In addition, synthetic LNO2 protected
isolated cardiomyocytes against simulated ischemia/reperfusion
injury. Biotin-tagged LNO2 replicated this cardioprotective effect,
and caused reversible modification of mitochondrial proteins. Thus,
we hypothesized that mitochondrial targets of LNO2 might play an
important role in cardioprotection. Previously we demonstrated that
LNO2 induced mitochondrial H+ leak viamodification of ANT. Further
studies revealed that LNO2 (1 µM) opened mitochondrial KATP
channels in a 5-HD and glybenclamide sensitive manner. Although
the molecular identity of the mKATP channel has not been fully
elucidated, we previously showed that complex (Cx) II might be
involved in regulation of mKATP channel activity. We found that LNO2
physically interacted with the 70 kDa subunit of Cx II and inhibited
its enzymatic activity. Notably, the cardioprotective effects of mild H+
leak, opening of mKATP channels and reversible inhibition of the respi-
ratory chain are well documented. Thus, our findings characterize
LNO2 as a pleotropic molecule which might recruit several protective
mitochondrial pathways to elicit cardioprotection.
doi:10.1016/j.bbabio.2010.04.244
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Nowadays, Doxorubicin (DOX) is probably one of the most effec-
tive anticancer drugs available in the clinic. However, the treatment
is usually followed by a cumulative and persistent cardiotoxicity.
Mitochondria have a critical role in DOX-mediated toxicity however
there are still doubts whereas mitochondrial toxicity is specific to the
heart. Therefore, the present work characterizes two differentmodels of
toxicity (acute vs. sub-chronic), regarding mitochondrial physiology
from three different tissues (heart, liver and kidney) from treated rats.
Wistar rats were sub-chronically (7 wks, 2 mg/kg) or acutely (20 mg/
kg) treated with DOX and allowed to rest oneweek or 24 h after the last
injection, respectively. Sub-chronically-treated animals showed a de-
crease in body mass gain during treatment while no changes were
observed in acute model. Plasma profile from both models was altered
but the sub-chronic treatment presented the most dramatic changes.
Histological analysis revealed the presence of lipid droplets in liver slices
from acutely treated rats. Regarding mitochondrial bioenergetics,
differences between saline and DOX-treated rats were observed: in the
acute model, differences included state 3 respiration in the liver and
kidneyand theADP/O in theheart. In the sub-chronicmodel, differences
regarding state 3 respiration in the heart and kidney was observed. We
also determined that cardiac mitochondria from sub-chronic-treated
animals presented a lower calcium loading capacity, which was not
observed in the other tissues. However, gene expression analyses
showed no alterations in the chronic model but interestingly, decreased
mRNA levels for the ANT, VDAC and increased CyP-D mRNA were
detected in the acute model. Aconitase activity, a sensitive marker of
oxidative stress, was decreased in the kidney (acute model) and in the
heart (sub-chronic model). In conclusion, data confirm that mitochon-
drial alterations result from DOX treatment, being more severe in the
heart and are very dependent on the treatment protocol. It remains to be
determined if mitochondrial alterations in organs such as liver and
kidneys are a specific and direct effect of DOX onmitochondria or if they
result of secondary effects of DOX on other targets.
The present work is supported by the Portuguese FCT (SFRH/BD/
36938/2007 to GP, PTDC/SAU-OSM/64084/2006 and PTDC/SAU-
OSM/104731/2008 to PO).
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Glycine, inhibitory neurotransmitter, has been found to be effective
against neuronal cell death in in vivo and in vitro models of ischemic
stroke. We have shown that glycine prevented respiratory index
depletion of mitochondria in the homogenate of the cerebral cortex after
24 h common carotid artery occlusion in rats, along with preventing the
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